Diabetic Retinopathy Drug Market Size

Diabetic Retinopathy Market size was valued at USD 9.49 billion in 2024 and is set to exceed USD 21.52 billion by 2037, expanding at over 6.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of diabetic retinopathy is estimated at USD 10.01 billion.

The growth of the market can be attributed to the rising prevalence of type 1 and type 2 diabetes, growing technological advancements in terms of developing effective retinopathy treatment and increasing geriatric population around the globe. According to the World Health Organization (WHO), 422 million people worldwide are suffering from diabetes. Along with these, availability of favorable health insurance policies for ophthalmologic surgeries in developed nations is also a significant factor expected to drive market growth in the coming years. Furthermore, growing adoption of minimal pain-inducing laser procedures is projected to offer lucrative opportunities to the market during the forecast period.